Updated Analysis of the Efficacy and Safety of Tisagenlecleucel in Pediatric and Young Adult Patients with Relapsed/Refractory (r/r) Acute Lymphoblastic LeukemiaStephan A. Grupp, Hidefumi Hiramatsu, Shannon L. Maude et al.|Blood|2018Cited by 94
Setting up and sustaining blood and marrow transplant services for children in middle-income economies: an experience-driven position paper on behalf of the EBMT PDWPLawrence Faulkner, Jacek Wachowiak, Stalin Ramprakash et al.|Bone Marrow Transplantation|2020Cited by 34
Tisagenlecleucel for the Treatment of Pediatric and Young Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia: Updated Analysis of the ELIANA Clinical TrialStephan A. Grupp, Hidefumi Hiramatsu, Shannon L. Maude et al.|Transplantation and Cellular Therapy|2019Cited by 17
Myeloablative Conditioning for First Allogeneic Hematopoietic Stem Cell Transplantation in Children with ALL: Total Body Irradiation or Chemotherapy? - a Multicenter EBMT-PDWP StudyAndré Willasch, Peter Bader, Christina Peters et al.|Blood|2017Cited by 2